HER2 Testing in MetastaticColorectal Cancer (mCRC)

Webinar presenters Jaclyn Hechtman, MD, Oncologic and Molecular Pathologist, Caris Life Sciences, and John Marshall, MD, Professor of Medicine and Oncology, Director, The Ruesch Center for the Cure of GI Cancers, Washington, DC, discuss how HER2 testing in mCRC opens a powerful new window for patients, testing methodology to identify HER2+ mCRC, a new treatment for patients with HER2+ mCRC, the importance of testing for HER2 in mCRC, and the efficacy and safety data from the MOUNTAINEER trial.